Extensive HCP Access and Research Coverage Across Chronic Kidney Disease, Dialysis, AKI, and Renal Transplantation
Konovo’s Nephrology Therapeutic Breakdown delivers a detailed analysis of global market research capabilities across key kidney and renal care conditions, including chronic kidney disease, dialysis, hepatorenal syndrome (HRS) type 1, acute kidney injury (AKI), and renal transplantation. Over the past three years, we have completed 235 projects and gathered more than 13,560 respondent completes from a verified panel of over 2 million healthcare professionals worldwide. Our reach spans nephrologists, primary care physicians, hospitalists, transplant surgeons, renal surgeons, and dialysis nurses across the Americas, Europe, and Asia. Supported by rigorous quality controls and proprietary recruitment technologies, Konovo provides accurate, representative data to help pharmaceutical, biotech, and medtech companies make faster, evidence-based decisions in the nephrology market.
